IP Verse

Prolyl Hydroxylase Inhibitors And Methods Of Use

Patent No. EP3357911 (titled "Prolyl Hydroxylase Inhibitors And Methods Of Use") was filed by Akebia Therapeutics on Jun 26, 2007. The application was issued on May 11, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
FIBROGENFeb 13, 2023CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3357911

AKEBIA THERAPEUTICS
Application Number
EP18158907A
Filing Date
Jun 26, 2007
Status
Granted And Under Opposition
Apr 8, 2022
Publication Date
May 11, 2022
External Links
Slate, Register , Google Patents